TrialLung cancer (Amsterdam, Netherlands)2020

Osimertinib in T790M-positive and -negative patients with EGFR-mutated advanced non-small cell lung cancer (the TREM-study).

Inger Johanne Zwicky Eide et al.PubMed ↗Publisher ↗

No numbers read from the abstract.